ACR-ASTRO立体定向体部放疗实践参数
美国放射学会(ACR)与美国放射肿瘤学会(ASTRO)合作制定立体定向体部放疗(SBRT)实践参数,明确SBRT为5次或更少分次向边界清晰颅外靶区投照较高单次剂量的技术,涵盖工作流程、人员资质、规范、文档、质控/安全/改进、模拟/治疗及随访。该参数用于协助从业者在有临床指征时提供安全恰当的SBRT治疗与照护,并按ACR规定的5年或更短周期复审修订。
要点
- SBRT定义为5次或更少分次向边界清晰的颅外靶区投照放射剂量,单次剂量通常高于常规放疗。
- 该实践参数覆盖工作流程、人员资质与职责、规范、文档、质控/安全/改进、模拟/治疗及随访。
- SBRT医学物理技术标准另见ACR-AAPM技术标准文件。
核心结论
- 该实践参数协助从业者在有临床指征时提供安全且恰当的SBRT治疗与照护。
- 随着技术与方法不断演进,文件将按ACR规定的5年或更短时间线进行复审、修订和更新。
研究设计与样本
- 由ACR放射肿瘤学委员会实践参数委员会与ASTRO合作修订,双方学会审核并批准该文件。
- 修订依据ACR网站所述「ACR实践参数与技术标准制定流程」进行。
- 因SBRT复杂性,另设专门文件制定SBRT医学物理技术标准(ACR-AAPM技术标准)。
诊断标准与关键数值
- SBRT定义为以5次或更少分次向边界清晰的颅外靶区投照放射剂量的治疗技术,通常采用高于常规放疗的单次剂量。
- 实践参数涉及工作流程、人员资质与职责、规范、文档、质控/安全/改进、模拟/治疗及随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM/OBJECTIVES/BACKGROUND: To standardize the practice of stereotactic body radiation therapy (SBRT), the American College of Radiology (ACR) and the American Society for Radiation Oncology (ASTRO) cooperatively developed the practice parameter for SBRT. SBRT is a treatment technique that delivers radiation dose to a well-defined extracranial target in 5 fractions or less and usually employs a higher dose per fraction than used in conventional radiation.
METHODS: The ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy was revised according to the process described on the ACR website ("The Process for Developing ACR Practice Parameters and Technical Standards," www.acr.org/ClinicalResources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters of the ACR Commission on Radiation Oncology in collaboration with the ASTRO. Both societies then reviewed and approved the document.
RESULTS: Given the complexities of SBRT, a separate document was created to develop a technical standard for the medical physics of SBRT (ACR-AAPM Technical Standard for Medical Physics Performance Monitoring of Stereotactic Body Radiation Therapy). Workflow, qualifications and responsibilities of personnel, specifications, documentation, quality control/safety/improvement, simulation/treatment, and follow-up were addressed in this practice parameter.
CONCLUSIONS: This practice parameter assists practitioners in providing safe and appropriate SBRT treatment and care for patients when clinically indicated. As technologies and techniques continue to evolve, this document will be reviewed, revised and renewed accordingly to a 5 year or sooner timeline specified by the ACR.
引用
- Chao ST, Dad LK, Dawson LA, et al. ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy. Am J Clin Oncol. 2020. PMID: 32404596. doi:10.1097/COC.0000000000000706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。